Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Meredith

Showing results (351-360 of 368) with videos related to

Pageof 37
Sort By:
Journal of the American College of Cardiology|September 27, 2014
Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II studyIan T Meredith Am, Darren L Walters, Nicolas Dumonteil, et al.
Circulation|March 20, 2016
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy StudyIan T Meredith, Jean-François Tanguay, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions|February 20, 2016
1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II StudyIan T Meredith, Darren L Walters, Nicolas Dumonteil, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 19, 2019
Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND studyDaniel J Blackman, Lennart Van Gils, Sabine Bleiziffer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 17, 2017
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohortNicolas Dumonteil, Ian T Meredith, Daniel J Blackman, et al.
Journal of the American Heart Association|October 24, 2019
Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III TrialChristopher U Meduri, Dean J Kereiakes, Vivek Rajagopal, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.
BMJ (Clinical Research Ed.)|November 8, 2013
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysisEliano P Navarese, Kenneth Tandjung, Bimmer Claessen, et al.
JACC. Cardiovascular Imaging|October 25, 2016
Noninvasive CT-Derived FFR Based on Structural and Fluid Analysis: A Comparison With Invasive FFR for Detection of Functionally Significant StenosisBrian S Ko, James D Cameron, Ravi K Munnur, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 23, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.
Pageof 37

Showing results (351-360 of 368) with videos related to

Sort By:
Pageof 37
Journal of the American College of Cardiology|September 27, 2014
Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II studyIan T Meredith Am, Darren L Walters, Nicolas Dumonteil, et al.
Circulation|March 20, 2016
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy StudyIan T Meredith, Jean-François Tanguay, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions|February 20, 2016
1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II StudyIan T Meredith, Darren L Walters, Nicolas Dumonteil, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 19, 2019
Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND studyDaniel J Blackman, Lennart Van Gils, Sabine Bleiziffer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 17, 2017
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohortNicolas Dumonteil, Ian T Meredith, Daniel J Blackman, et al.
Journal of the American Heart Association|October 24, 2019
Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III TrialChristopher U Meduri, Dean J Kereiakes, Vivek Rajagopal, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.
BMJ (Clinical Research Ed.)|November 8, 2013
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysisEliano P Navarese, Kenneth Tandjung, Bimmer Claessen, et al.
JACC. Cardiovascular Imaging|October 25, 2016
Noninvasive CT-Derived FFR Based on Structural and Fluid Analysis: A Comparison With Invasive FFR for Detection of Functionally Significant StenosisBrian S Ko, James D Cameron, Ravi K Munnur, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 23, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.
Pageof 37